This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease | MicrobiomeTrials
← Back to trials NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-05-12Est. Completion: 2028-12-31
Enrollment target: 425 participantsLocations Sun City Clinical Research, Glendale, Arizona, United States Om Research LLC, Lancaster, California, United States Hoag Memorial Hospital Presbyterian;Hoag Center for Research and Education, Newport Beach, California, United States Empire Clinical Research, Pomona, California, United States Stanford Medicine Outpatient Center, Redwood City, California, United States Clinical Applications Laboratories, Inc., San Diego, California, United States Amicis Research Center, Santa Clarita, California, United States Peak Gastroenterology Associates, Colorado Springs, Colorado, United States J&A Clinical Research, Doral, Florida, United States Auzmer Research, Lakeland, Florida, United States Galenus Group Inc, Lehigh Acres, Florida, United States Homestead Associates in Research, Inc., Miami, Florida, United States Allied Biomedical Research Institute, Inc, Miami, Florida, United States Rejuvaline Medical Research, Miami, Florida, United States Miami Beach Clinical Research Center, Miami Beach, Florida, United States Other microbiome trials you might be interested in Crohn Disease (CD)
This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of standard-dose tumor necrosis …
Guangzhou, China Est. completion Dec 31, 2028
Crohn's Disease
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to s…
Dothan, United States Est. completion Oct 30, 2028
Eminat Research Group, Miramar, Florida, United States
Digestive and Liver Center of Florida, Orlando, Florida, United States
Advanced Medical Research Center, Port Orange, Florida, United States
Santos Research Center, CORP, Tampa, Florida, United States
Cleveland Clinic Florida, Weston, Florida, United States
The University of Chicago, Chicago, Illinois, United States
Robley Rex VA Medical Center, Louisville, Kentucky, United States
Baton Rouge General Medical Center, Baton Rouge, Louisiana, United States
Louisiana Research Center - GastroIntestinal Associates, Shreveport, Louisiana, United States
Mercy Medical Center, Baltimore, Maryland, United States
Chevy Chase Clinical Research, Chevy Chase, Maryland, United States
University of Massachusetts Memorial Medical Center, North Worcester, Massachusetts, United States
Gastroenterology Associates of Western Michigan, P.L.C., Wyoming, Michigan, United States
Gastrointestinal Associates Research, Flowood, Mississippi, United States
Virtua Crohns and Colitis Center, Moorestown, New Jersey, United States
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States
Ellipsis Research Group, Brooklyn, New York, United States
Intercity Gastroenterology, Fresh Meadows, New York, United States
James J Peters Veterans Affairs Medical Center, The Bronx, New York, United States
Digestive Disease Medicine of Central New York, Utica, New York, United States
Charlotte Gastroenterology and Hepatology, P.L.L.C, Charlotte, North Carolina, United States
Peters Medical Research (PMR), LLC, High Point, North Carolina, United States
Clinical Inquest Center, Beavercreek, Ohio, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
University of Texas Southwestern Medical Center - Multidisciplinary Spine Clinic - James W. Aston Ambulatory Care Center, Dallas, Texas, United States
GI Alliance - Fort Worth, Fort Worth, Texas, United States
GI Alliance, Garland, Texas, United States
Integrity Advanced Therapeutics PLLC, Houston, Texas, United States
Texas Digestive Disease Consultants-Lubbock powered by GI Alliance, Lubbock, Texas, United States
Carta - Clinical Associates In Research Therapeutics Of America;LLC, San Antonio, Texas, United States
University of Texas Health Center at Tyler, Tyler, Texas, United States
TDDC GI Alliance research Webster, Webster, Texas, United States
University Physicians and Surgeons Inc, dba Marshall Health, Huntington, West Virginia, United States
Instituto Medico CER, Quilmes, Argentina
CICE 9 de Julio, San Miguel de Tucumán, Argentina
Macquarie University Hospital, Macquarie Park, New South Wales, Australia
Coral Sea Clinical Research Institute, Mackay, Queensland, Australia
Footscray Hospital, Footscray, Victoria, Australia
Royal Melbourne Hospital, Parkville, Victoria, Australia
Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria
Klinikum Wels-Grieskirchen, Wels, Austria
CHU St Pierre (St Pierre), Brussels, Belgium
UZ Brussel, Brussels, Belgium
Cliniques Universitaires St-Luc, Brussels, Belgium
Instituto Lobus Unimed Volta Redonda, Volta Redonda, Rio de Janeiro, Brazil
Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil
Newdata Clinical Trials, Aracaju, Sergipe, Brazil
CECIP - Centro de Estudos Clínicos do Interior Paulista, Jaú, São Paulo, Brazil
Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto, São Paulo, Brazil
Hospital Sírio-Libanês, São Paulo, São Paulo, Brazil
MC " Sveti Ivan Rilski Chudotvorets- 2010, Plovdiv, Bulgaria
Barrie GI Associates, Barrie, Ontario, Canada
GNRR Digestive Clinics and Research Center Inc., Brampton, Ontario, Canada
London Health Sciences Centre Uni Campus, London, Ontario, Canada
LDDI Clinical Trials Inc., London, Ontario, Canada
Toronto Immune and Digestive Health Institute, North YORK, Ontario, Canada
CIUSSS de l Est de l Ile de Montreal - Hopital Maisonneuve Rosemont, Montreal, Quebec, Canada
Medicina de Precisión - Celerity, Las Condes, Chile
Centro de Investigación Clínica UC-CICUC, Santiago, Chile
First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China
The First Affilliated Hospital of Kunming Medical University, Kunming, Yunnan, China
Jinhua municipal central hospital, Jinhua, Zhejiang, China
Beijing Union Hospital, Beijing, China
Sichuan Provincial People's Hospital, Chengdu, China
Guangzhou First People's Hospital, Guangzhou, China
Zhujiang Hospital, Southern Medical University, Guangzhou, China
Hainan General Hospital, Haikou, China
Huizhou First Hospital, Huizhou, China
The Second Affiliated Hospital of Nanchang University, Nanchang, China
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Shengjing Hospital of China Medical University, Shenyang, China
Hebei Medical University - The Second Hospital, Shijiazhuang, China
The Second Affiliated Hospital of Soochow University, Suzhou, China
The Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China
The First Affiliated Hospital of Xiamen University, Xiamen, China
Affiliated Hospital of Jiangsu University, Zhenjiang, China
Hospital Universitario San Ignacio, Bogotá, Colombia
Clínica de la Mujer, Bogotá, Colombia
Clinica Colsanitas S.A. - Sede Clinica Reina Sofia, Bogotá, Colombia
Oncomedica S.A., Montería, Colombia
Borzan Polyclinic, Osijek, Croatia
Clinical Hospital Centre Zagreb, Zagreb, Croatia
Hepato-Gastroenterologie HK, s.r.o., Hradec Králové, Czechia
Fakultni nemocnice Ostrava, Ostrava - Poruba, Czechia
Institutu Klinicke a Experimentaini Mediciny (IKEM);Klinika hepatogastroenterologie, Prague, Czechia
ISCARE a.s., Prague, Czechia
Krajska zdravotni, a.s. ? Masarykova nemocnice v Usti nad Labem, o.z., Ocni oddeleni, Ústí nad Labem, Czechia
Centre hospitalier Lyon Sud, Pierre-Bénite, Rhône, France
CHU Tours - Hôpital Trousseau, Chambray-lès-Tours, France
CHU Clermont Ferrand - Hôpital d'Estaing, Clermont-Ferrand, France
Hôpital Henri Mondor, Créteil, France
CH Dptal Les Oudairies, La Roche-sur-Yon, France
CHRU de Lille - Hopital Claude Huriez, Lille, France
Hopital Dupuytren, Limoges, France
Hopital Saint-Eloi, Montpellier, France
Institut des MICI, Clinique Ambroise Paré, Neuilly-sur-Seine, France
Hôpital Saint-Louis, Paris, France
Hôpital de Brabois Adultes, Vandœuvre-lès-Nancy, France
Universitätsklinikum Heidelberg, Heidelberg, Germany
Klinikum Ernst von Bergmann, Potsdam, Germany
Észak-Pesti Centrumkórház-Honvédkórház, Budapest, Hungary
Geomedical Orvosi Kft, Budapest, Hungary
Semmelweis Egyetem, Budapest, Hungary
Endomedix Kft., Budapest, Hungary
Vas-Oxy Egeszsegugyi Kft, Szombathely, Hungary
Shree Giriraj Multispeciality Hospital, Rajkot, Gujarat, India
Surat Institute of Digestive Sciences Hospitals, Surat, Gujarat, India
Gujarat Gastro and Vascular Hospital, Surat, Gujarat, India
Amrita Institute of Medical Sciences, Kochi, Kerala, India
MIDAS Multispeciality Hospital, Nagpur (urban), Maharashtra, India
All India Institute Of Medical Sciences (AIIMS), New Delhi, National Capital Territory of Delhi, India
SR Kalla Memorial Gastro & General Hospital, Jaipur, Rajasthan, India
AIG Hospitals, Gachibowli, Telangana, India
Gandhi Hospital, Secunderabad, Telangana, India
Yashoda Hospitals, Secunderabad, Telangana, India
Shaare Zedek Medical Center, Jerusalem, Israel
Hadassah Medical Center, Jerusalem, Israel
Ospedale Madonna delle Grazie, Matera, Basilicate, Italy
Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi-Via Massarenti, Bologna, Emilia-Romagna, Italy
Policlinico Universitario Campus Biomedico Di Roma, Rome, Lazio, Italy
Policlinico Universitario Agostino Gemelli, Rome, Lazio, Italy
Asst Degli Spedali Civili Di Brescia, Brescia, Lombardy, Italy
IRCCS Ospedale San Raffaele, Milan, Lombardy, Italy
I.R.C.C.S Policlinico San Donato, San Donato Milanese (MI), Lombardy, Italy
IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Veneto, Italy
Gastromed Kralisz, Romatowski, Stachurska sp.j., Bia?ystok, Poland
Medical Center Kermed, Bydgoszcz, Poland
Szpital Miejski sw. Jana Paw?a II w Elblagu, Elblag, Poland
Osrodek Badan Klinicznych Bd Research, I?awa, Poland
MZ Badania Slowik Zymla Sp.j., Knurów, Poland
Centrum Medyczne Promed, Krakow, Poland
Amicare Sp. z o.o. S.K., Lodz, Poland
Medrise sp z o.o, Lublin, Poland
Clinical Research Center Sp. z o.o. MEDIC-R Spó?ka Komandytowa, Poznan, Poland
EMC Instytut Medyczny SA, Późna, Poland
Gabinety Lekarskie Rivermed, Późna, Poland
Endoskopia Sp. z o.o., Sopot, Poland
Sonomed Sp. z o.o., Szczecin, Poland
Centrum Zdrowia-MDM, Warsaw, Poland
Medon Clinical Research sp. z o.o, Warsaw, Poland
Vivamed Spolka Z Ograniczona Odpowiedzialnoscia, Warsaw, Poland
PlanetMed sp. z o.o., Wroc?aw, Poland
Hospital de Braga, Braga, Portugal
Hospital de Santa Maria, Lisbon, Portugal
Hospital de Sao Joao, Porto, Portugal
Centro Hospitalar de Entre Douro e Vouga - H. São Sebastião, Santa Maria da Feira, Portugal
Hospital Sao Teotonio, Viseu, Portugal
Spital Digenio - Centrul de Excelen?? în Afec?iuni Digestive, Cluj-Napoca, Romania
ABAWI spol. s r.o., Bratislava, Slovakia
KM Management spol. s r.o., Nitra, Slovakia
Yeungnam University Medical Center, Daegu, South Korea
Fundacion Hospital de Alcorcon, Alcorcón, Madrid, Spain
Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
Hospital General Universitario Gregorio Maranon, Madrid, Spain
Hospital Clinico Univ. Lozano Blesa, Zaragoza, Spain
Southmead Hospital, Bristol, United Kingdom
Fairfield General Hospital, Bury, United Kingdom
Bronglais General Hospital, Llanrhystud, United Kingdom
Royal London Hospital, London, United Kingdom
Stepping Hill Hospital, Stockport, United Kingdom Contact Fastest response: use the inquiry form. No email attachments. https://www.gene.com/contact-us/submit-medical-inquiry
Phase 2
Recruiting
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.
Birmingham, United States Est. completion May 23, 2025